SR 144528, the first potent and selective antagonist of the CB2 cannabinoid receptor

Journal of Pharmacology and Experimental Therapeutics

Volumn 284, Issue 2, 1998, Pages 644-650

  Rinaldi Carmona, Murielle ^a   Barth, Francis ^a   Millan, José ^a   Derocq, Jean Marie ^a   Casellas, Pierre ^a   Congy, Christian ^a   Oustric, Didier ^a   Sarran, Martine ^a   Bouaboula, Monsif ^a   Calandra, Bernard ^a   Portier, Marielle ^a   Shire, David ^a   Brelière, Jean Claude ^a   Le Fur, Gérard ^a  

^a SANOFI   (France)

Author keywords

[No Author keywords available]

Indexed keywords

4 (1,1 DIMETHYLHEPTYL) 1',2',3',4',5',6' HEXAHYDRO 2,3' DIHYDROXY 6' (3 HYDROXYPROPYL)BIPHENYL; ADENYLATE CYCLASE; CANNABINOID RECEPTOR; CANNABINOID RECEPTOR AGONIST; CANNABINOID RECEPTOR ANTAGONIST; MITOGEN ACTIVATED PROTEIN KINASE; N [ENDO 1,3,3 TRIMETHYLBICYCLO[2.2.1]HEPTAN 2 YL] 5 (4 CHLORO 3 METHYLPHENYL) 1 (4 METHYLBENZYL)PYRAZOLE 3 CARBOXAMIDE; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; B LYMPHOCYTE ACTIVATION; BRAIN; CHO CELL; DRUG POTENCY; DRUG RECEPTOR BINDING; DRUG SELECTIVITY; ENZYME ACTIVITY; HUMAN; HUMAN CELL; ISOTOPE LABELING; MALE; MOUSE; NONHUMAN; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; RECEPTOR AFFINITY; RECEPTOR BLOCKING; SPLEEN;

EID: 5644254040     PISSN: 00223565     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (34)

1. Abita JP, Chicheportiche R, Schweitz H and Lazdunski M (1977) Effects of neurotoxins (veratridine, sea anemone toxin, tetrodotoxin) on transmitter accumulation and release by nerve terminals in vitro. Biochemistry 16:1838-1843.
2. Bouaboula M, Rinaldi M, Carayon P, Carillon C, Delpech B, Shire D, Le Fur G and Casellas P (1993) Cannabinoid-receptor expression in human leucocytes. Eur J Biochem 214:173-180.
3. Bouaboula M, Poinot-Chazel C, Bourrié B, Calandra B, Rinaldi-Carmona M, Le Fur G and Casellas P (1995a) Activation of mitogen-activated protein kinases by stimulation of the central cannabinoid receptor CB1. Biochem J 312:637-641.
4. Bouaboula M, Bourrié B, Rinaldi-Carmona M, Shire D, Le Fur G and Casellas P (1995b) Stimulation of cannabinoid receptor CB1 induces krox-24 expression in human astrocytoma cells. J Biol Chem 270:13973-13980.
5. Bouaboula M, Poinot-Chazel C, Marchand J, Canat X, Bourrié B, Rinaldi-Carmona M, Calandra B, Le Fur G and Casellas P (1996) Signalling pathway associated with stimulation of CB2 peripheral cannabinoid receptor. Involvement of both mitogen-activated protein kinases and induction of Krox-24 expression. Eur J Biochem 237:704-711.
6. D'Ambra TE, Estep KG, Bell MR, Eissenstat NA, Josef KA, Ward SJ, Haycock DA, Baizman ER, Casanio FM, Beglin NC, Chippari SM, Greco JD, Kullnig RK and Daley GT (1992) Conformationally restrained analogues of pravadoline: nanomolar potent, enantioselective, (aminoalkyl)indole agonists of the cannabinoid receptor. J Med Chem 35:124-135.
7. Derocq J-M, Ségui M, Marchand J, Le Fur G and Casellas P (1995) Cannabinoids enhance human B-cell growth at low nanomolar concentrations. FEBS Lett 369: 177-182.
8. Devane WA, Dysarz FA, Johnson MR, Melvin LS and Howlett AC (1988) Determination and characterization of a cannabinoid receptor in rat brain. Mol Pharmacol 34:605-613.
9. Devane WA, Hanus L, Breuer A, Pertwee RG, Stevenson LA, Griffin G, Gibson D, Mandelbaum A, Etinger A and Mechoulam R (1992) Isolation and structure of a brain constituent that binds to the cannabinoid receptor. Science 258:1946-1949.
10. Felder CC, Joyce KE, Briley EM, Mansouri J, Mackie K, Blond O, Lai Y, Ma A and Mitchell RL (1995) Comparison of the pharmacology and signal transduction of the human cannabinoid CB1 and CB2 receptors. Mol Pharmacol 48:443-450.
11. Frodin M, Peraldi P and Van Obberhen E (1994) Cyclic AMP activates the mitogen-activated protein kinase in PC12 cells. J Biol Chem 269:6207-6214.
12. Galiègue S, Mary S, Marchand J, Dussossoy D, Carrière D, Carayon P, Bouaboula M, Shire D, Le Fur G and Casellas P (1995) Expression of central and peripheral cannabinoid receptors in human tissues and leucocytes subpopulations. Eur J Biochem 232:54-61.
13. Gallant M, Dufresne C, Gareau Y, Guay D, Leblanc Y, Prasit P, Rochette C, Sawyer N, Slipetz D, Tremblay N, Metters K and Labelle M (1996) New class of potent ligands for the human peripheral cannabinoid receptor. Bioorg Med Chem Lett 6:2263-2268.
14. Gérard CM, Mollereau C, Vassart G and Parmentier M (1991) Molecular cloning of a human cannabinoid receptor which is also expressed in testis. Biochem J 279: 129-134.
15. Graham FL and Van der Eb AJ (1973) Transformation of rat cells by DNA of human adenovirus 5. Virology 54:536-539.
16. Howlett AC and Fleming RM (1984) Cannabinoid inhibition of adenylate cyclase. Pharmacology of the response in neuroblastoma cell membranes. Mol Pharmacol 26:532-538.
17. Jung M, Calassi R, Rinaldi-Carmona M, Chardenot P, Le Fur G, Soubrié P and Oury-Donat F (1997) Characterization of CB1 receptors on rat neuronal cell cultures: binding and functional studies using the selective receptor antagonist SR 141716A. J Neurochem 68:402-409.
18. Kaminski NE, Abood M, Kessler FK, Martin BR and Schatz AR (1992) Identification of a functionally relevant cannabinoid receptor on mouse spleen cells that is involved in cannabinoid-mediated immune modulation. Mol Pharmacol 42:736-742.
19. Kearn CS and Hillard CJ (1997) Rat microglial cells express the peripheral-type cannabinoid receptor (CB2) which is negatively coupled to adenylyl cyclase, in Abstracts of the International Cannabinoid Research Society 1997 Symposium on the Cannabinoids, p 61, June 20-22, Stone Mountain, GA.
20. Mackie K and Hille B (1992) Cannabinoids inhibit N-type calcium channels in neuroblastoma-glioma cells. Proc Natl Acad Sci USA 89:3825-3829.
21. Mackie K, Lai Y, Westenbroek R and Mitchell R (1995) Cannabinoids activate an inwardly rectifying potassium conductance and inhibit Q-type calcium currents in AtT20 cells transfected with rat brain cannabinoid receptor. J Neurosci 15:6552-6561.
22. Matsuda LA, Lolait SJ, Brownstein BJ, Young AC and Bonner TL (1990) Structure of a cannabinoid receptor and functional expression of the cloned cDNA. Nature (Lond) 346:561-564.
23. Miloux B and Lupker JH (1994) Rapid isolation of highly productive recombinant Chinese hamster ovary cell lines. Gene 149:341-344.
24. Munro S, Thomas KL and Abu-Shaar M (1993) Molecular characterization of a peripheral receptor for Cannabinoids. Nature (Lond) 365:61-65.
25. Pertwee RG, Griffin G, Lainton J and Huffman J (1995) Pharmacological characterization of three novel cannabinoid receptor agonists in the mouse isolated vas deferens. Eur J Pharmacol 284:241-247.
26. Rinaldi-Carmona M, Barth F, Héaulme M, Shire D, Calandra B, Congy C, Martinez S, Maruani J, Néliat G, Caput D, Ferrara P, Soubrié P, Brelière J-C and Le Fur G (1994) SR141716A, a potent and selective antagonist of the brain cannabinoid receptor. FEBS Lett 350:240-244.
27. Rinaldi-Carmona M, Barth F, Héaulme M, Alonso R, Shire D, Congy C, Soubrié P, Brelière J-C and Le Fur G (1995) Biochemical and pharmacological characterisation of SR141716A, the first potent and selective brain cannabinoid receptor antagonist. Life Sci 56:1941-1947.
28. Rinaldi-Carmona M, Calandra B, Shire D, Bouaboula M, Oustric D, Barth F, Casellas P, Ferrara P and Le Fur G (1996) SR141716A, Characterization of two cloned human CB1 cannabinoid receptor isoforms. J Biol Chem 278:871-878.
29. Shire D, Calandra B, Rinaldi-Carmona M, Oustric D, Pessègue B, Bonnin-Cabanne O, Le Fur G, Caput D and Ferrara P (1996) Molecular cloning, expression and function of the murine CB2 peripheral cannabinoid receptor. Biochim Biophys Acta 1307:132-136.
30. Skaper SD, Buriani A, Dal Toso R, Petrelli L, Romanello S, Facci L and Leon A (1996) The ALIamide palmitoylethanolamide and Cannabinoids, but not anandamide, are protective in a delayed postglutamate paradigm of excitotoxic death in cerebellar granule neurons. Proc Natl Acad Sci USA 93:3984-3989.
31. Slipetz D, O'Neill G, Favreau L, Dufresne C, Gallant M, Gareau Y, Guay D, Labelle M and Metters C (1995) Activation of the human peripheral cannabinoid receptor results in inhibition of adenylyl cyclase. Mol Pharmacol 48:352-361.
32. Spector T (1975) Refinement of the coomassie blue method of protein quantification. Anal Biochem 86:142-146.
33. Ward S, Mastriani D, Casiano F and Arnold R (1990) Pravadoline: profile in isolated tissue preparations. J Pharmacol Exp Ther 255:1230-1239.
34. Westlake TM, Hewlett AC, Bonner TI, Matsuda LA and Herkenham M (1994) Cannabinoid receptor binding and messenger RNA expression in human brain. An in vitro receptor autoradiography and in situ hybridization histochemistry study of normal aged and Alzheimer's brains. Neurosciences 63:637-652.